PedAM
Pediatric Disease Annotations & Medicines
| Disease | portal hypertension |
| Phenotype | |liver cirrhosis |
| Sentences | 62 |
| PubMedID- 22114590 | We have a long-lasting interest in applying endoscopic ultrasound for the study of features of portal hypertension in patients with liver cirrhosis [2, 3, 11, 21]. |
| PubMedID- 23855493 | Impaired endothelial function is a major cause of portal hypertension in liver cirrhosis. |
| PubMedID- 24331694 | [non-invasive assessment of portal hypertension in patients with liver cirrhosis using fibroscan transient elastography]. |
| PubMedID- 24974920 | So, the current study was conducted to evaluate cardiac systolic and diastolic functions in liver cirrhosis patients with portal hypertension by conventional doppler echocardiography and tdi. |
| PubMedID- 23247799 | 1endoscopic appearance of small bowel lesions related to portal hypertension in patients with liver cirrhosis. |
| PubMedID- 25812120 | In some patients liver fibrosis leads to liver cirrhosis with portal hypertension, hepatocellular dysfunction and increased risk of hepatocellular carcinoma [2,3]. |
| PubMedID- 24400086 | The hemodynamic alteration of portal hypertension in patients with liver cirrhosis contributes to most of the clinical manifestations of the disease: gastrointestinal bleeding, hepatic encephalopathy, ascites and renal failure. |
| PubMedID- 26302944 | Additionally, portal hypertensive enteropathy (phe) associated with portal hypertension in patients with liver cirrhosis has been reported to be a major cause of gastrointestinal bleeding [16]. |
| PubMedID- 24775062 | Myeloproliferative disorder, liver cirrhosis with portal hypertension, deficiency of natural anticoagulant proteins such as protein c or atiii as well as hepatocellular carcinoma are the most frequent causes of portal vein thrombosis [1]. |
| PubMedID- 24673975 | Thrombocytopenia: in time, liver cirrhosis leads to portal hypertension. |
| PubMedID- 25374673 | Future therapy of portal hypertension in liver cirrhosis - a guess. |
| PubMedID- 23787475 | Oct is a somatostatin analogue that has few side effects, and its injection is clinically used for lowering the portal hypertension associated with liver cirrhosis [5]. |
| PubMedID- 22957328 | Liver elastography for the diagnosis of portal hypertension in patients with liver cirrhosis. |
| PubMedID- 25499848 | Portal hypertensive gastropathy (ghp) is a complication of portal hypertension usually associated with liver cirrhosis. |
| PubMedID- 24502094 | Results: sixteen patients were found to have liver cirrhosis, three of them with portal hypertension. |
| PubMedID- 24563796 | Relevant diagnoses of the patient were (i) known hypertensive cardiac disease (transthoracic echocardiography 6 months before had shown a lv-ef of 54% and a light mitral and tricuspid insufficiency) and (ii) liver cirrhosis with portal hypertension. |
| PubMedID- 22591184 | Soluble cd163, a marker of kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis. |
| PubMedID- 25888771 | Introduction: esophagogastric varices bleeding is a common complication due to portal hypertension in patients with liver cirrhosis. |
| PubMedID- 21827004 | Reconstructed cta images showed that different collateral vessels were developed at the end-stage of chronic liver cirrhosis due to severe portal hypertension. |
| PubMedID- 22009385 | Background: portal hypertension associated with liver cirrhosis increases the risk of postoperative complications after liver resection for hepatocellular carcinoma (hcc). |
| PubMedID- 26159275 | This might explain the pathophysiologic correlation between microbial infections and portal hypertension in patients with liver cirrhosis. |
| PubMedID- 25038804 | Estimation of the severity of portal hypertension in patients with liver cirrhosis is another major use of liver stiffness measurements. |
| PubMedID- 20653965 | Patent paraumbilical and abdominal subcutaneous veins are found frequently as collaterals in patients due to portal hypertension, mainly associated with liver cirrhosis [1,2]. |
| PubMedID- 21701671 | She was a known case of cryptogenic liver cirrhosis with portal hypertension. |
| PubMedID- 23586850 | Reported a 29% in-hospital mortality after colorectal surgery among patients with liver cirrhosis complicated by portal hypertension and 14% in patients with compensated liver cirrhosis [10]. |
| PubMedID- 25336484 | Contrast-enhanced sonography for quantitative assessment of portal hypertension in patients with liver cirrhosis. |
| PubMedID- 21506350 | An analysis of 115 liver cirrhosis patients with portal hypertension was made to find out which of them had variceal bleeding and high risk of its development. |
| PubMedID- 23452051 | Functional variants of enos and inos genes have no relationship to the portal hypertension in patients with liver cirrhosis. |
| PubMedID- 21460144 | Methods: spectral doppler sonography of the hepatic vein was performed on 22 consecutive patients who underwent hvpg measurement for portal hypertension with liver cirrhosis. |
| PubMedID- 24697006 | In second pregnancy, medically induced abortion was performed in the 12th week because of deterioration of the underlying disease, liver cirrhosis with portal hypertension. |
| PubMedID- 25701619 | Objective: we have compared the influences of three surgical strategies on the occurrence and development of portal vein thrombosis (pvt) in patients with liver cirrhosis complicated by portal hypertension (pht) in this study. |
| PubMedID- 25933224 | liver cirrhosis with portal hypertension is characterized by systemic and splanchnic vasodilatory substances release, especially nitric oxide (no) and prostacyclin [3], which lead to hyperdynamic circulatory status, and further increased mesenteric blood flow and portal inflow. |
| PubMedID- 26378453 | portal hypertension may develop in patients with liver cirrhosis, as a result of an increased intrahepatic vascular resistance, reduced systemic vascular resistance and increased portal inflow. |
| PubMedID- 24339715 | Severe chronic illness included liver cirrhosis with portal hypertension, new york heart association class iv congestive heart failure, chronic respiratory disease, end-stage renal disease, or an immune-compromised state (e.g., leukemia, lymphoma, or aids). |
| PubMedID- 23547461 | [the protective effect of n-acetylcysteine magnesium against liver cirrhosis with portal hypertension in rat]. |
| PubMedID- 21802316 | Purpose: to develop a clinically relevant porcine model of liver cirrhosis with portal hypertension by means of hepatic transarterial embolization. |
| PubMedID- 25374728 | Variceal bleeding is the major complication of portal hypertension in patients with liver cirrhosis. |
| PubMedID- 24574834 | Variceal bleeding is one of the most fatal complications of portal hypertension in patients with liver cirrhosis [2,17]. |
| PubMedID- 23403613 | The only inclusion criterion was the presence of clinical portal hypertension with intrinsic liver cirrhosis. |
| PubMedID- 25543221 | liver cirrhosis with portal hypertension is also associated with the presence of pahs in 1-2% of cases. |
| PubMedID- 23729979 | Portal vein interventions in liver transplant recipients represent a group of interventions in the management of several disease entities including portal vein stenosis, portal vein thrombosis, and recurrent liver cirrhosis with portal hypertension with and without gastric varices. |
| PubMedID- 22577563 | portal hypertension in liver cirrhosis results from the anatomical changes and the development of contractile element in the liver vascular bed secondary to progressive hepatic fibrosis and formation of regenerative nodules [1, 2]. |
| PubMedID- 26370856 | Hypothyroidism enhanced portal hypertension in a patient with alcoholic liver cirrhosis, resulting in the development of ascites. |
| PubMedID- 26412302 | Additionally, neo-angiogenesis has been identified as a key mechanism in the progression of liver cirrhosis with portal hypertension3. |
| PubMedID- 20652243 | Four patients underwent splenectomy because of liver cirrhosis with portal hypertension and gastroesophageal variceal bleeding. |
| PubMedID- 21705304 | A detailed interview and examination by occupational health and other medical specialists revealed that the patient had been suffering from wilson's disease from the age of 13, and had now developed hepatic manifestations (compensated liver cirrhosis with portal hypertension), neurological manifestations (dystonia, dysarthria, muscle weakness, vertigo), and psychiatric manifestations (depression, insomnia, cognitive impairment) of the disease, including problems partially caused by long-lasting treatment with copper chelating agents (neurological and haematological manifestations). |
| PubMedID- 24820919 | Case background: ascites appears mainly as a consequence of portal hypertension in patients with liver cirrhosis, or can be caused by several other causes, such us congestive heart failure, peritoneal malignancy, or tuberculosis. |
| PubMedID- 21606920 | The experimental study of liver cirrhosis with portal hypertension syndrome, modeled in 38 dogs, has been performed. |
| PubMedID- 25892988 | This study aimed to further investigate portal venous remodeling in the pathogenesis of liver cirrhosis with portal hypertension, thereby guiding its prevention and treatment. |
| PubMedID- 23801819 | Subsequent investigations revealed the presence of hepatitis b with secondary liver cirrhosis, complicated by portal hypertension and esophageal varices. |
Page: 1 2